Dermapharm Holding SE (LON: 0A5J)
London
· Delayed Price · Currency is GBP · Price in EUR
39.65
0.00 (0.00%)
At close: Jan 31, 2025
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 314.56M EUR in the quarter ending September 30, 2024, with 9.48% growth. This brings the company's revenue in the last twelve months to 1.17B, up 0.17% year-over-year. In the year 2023, Dermapharm Holding SE had annual revenue of 1.15B with 10.59% growth.
Revenue (ttm)
1.17B EUR
Revenue Growth
+0.17%
P/S Ratio
n/a
Revenue / Employee
335.70K EUR
Employees
3,497
Market Cap
1.79B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
Dec 31, 2019 | 714.38M | 130.28M | 22.30% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |